Inactive Instrument
Pressure BioSciences, Inc. Share Price Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 119K 108K 204K 13.88M 205K 1.43M 560K 7.06M 538K 527K 22.69M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.49M 19.05M 17.34M 32.71M 2.22B 32.87M 229M 89.7M 1.13B 86.17M 84.28M 3.63B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 15/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 02/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 23/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 31/12/1991 | |
Jeffrey Peterson
CHM | Chairman | 70 | 07/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 07/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.93% | +0.84% | +22.72% | +31.99% | 241B | ||
| +1.08% | +3.80% | +7.25% | +1.19% | 153B | ||
| +2.06% | +5.66% | -5.39% | +43.38% | 147B | ||
| +1.64% | -1.16% | -55.85% | -18.02% | 60.93B | ||
| +1.15% | +0.02% | +12.50% | +15.62% | 48.56B | ||
| +2.30% | +4.07% | -19.37% | -17.50% | 47.69B | ||
| +1.41% | +2.32% | +21.11% | +54.14% | 47.41B | ||
| +3.96% | +5.04% | -1.88% | +41.28% | 46.12B | ||
| +1.08% | +1.94% | +32.39% | +62.22% | 42.16B | ||
| Average | +0.97% | +0.37% | +1.50% | +23.81% | 92.62B | |
| Weighted average by Cap. | +0.79% | +0.46% | +5.23% | +24.21% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.54M 1.44M 1.31M 2.47M 167M 2.48M 17.28M 6.76M 85.19M 6.49M 6.35M 274M | 1.98M 1.77M 1.64M 1.49M 2.82M 191M 2.83M 19.77M 7.73M 97.42M 7.43M 7.26M 313M |
| Net income | -16.08M -14.35M -13.34M -12.15M -22.92M -1.56B -23.03M -161M -62.84M -792M -60.37M -59.05M -2.54B | -29.31M -26.17M -24.33M -22.15M -41.78M -2.84B -41.99M -293M -115M -1.44B -110M -108M -4.64B |
| Net Debt | 20.53M 18.32M 17.04M 15.51M 29.26M 1.99B 29.4M 205M 80.23M 1.01B 77.07M 75.39M 3.25B | 22.8M 20.36M 18.93M 17.23M 32.51M 2.21B 32.66M 228M 89.14M 1.12B 85.63M 83.76M 3.61B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















